Q32 Bio, Inc. (QTTB)
8.65
-0.15
(-1.70%)
USD |
NASDAQ |
Oct 23, 16:00
8.63
-0.02
(-0.23%)
After-Hours: 20:00
Q32 Bio Price to Book Value : 1.939 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.939 |
| October 22, 2026 | 1.972 |
| October 21, 2026 | 1.943 |
| October 20, 2026 | 1.932 |
| October 19, 2026 | 1.746 |
| October 16, 2026 | 1.686 |
| October 15, 2026 | 1.742 |
| October 14, 2026 | 1.795 |
| October 13, 2026 | 1.806 |
| October 12, 2026 | 1.959 |
| October 09, 2026 | 1.869 |
| October 08, 2026 | 1.813 |
| October 07, 2026 | 1.791 |
| October 06, 2026 | 1.818 |
| October 05, 2026 | 1.876 |
| October 02, 2026 | 1.845 |
| October 01, 2026 | 1.849 |
| September 30, 2026 | 1.854 |
| September 29, 2026 | 2.136 |
| September 28, 2026 | 2.069 |
| September 25, 2026 | 1.966 |
| September 24, 2026 | 2.066 |
| September 23, 2026 | 2.143 |
| September 22, 2026 | 2.369 |
| September 21, 2026 | 2.347 |
| Date | Value |
|---|---|
| September 18, 2026 | 2.362 |
| September 17, 2026 | 2.434 |
| September 16, 2026 | 2.461 |
| September 15, 2026 | 2.504 |
| September 14, 2026 | 2.445 |
| September 11, 2026 | 2.488 |
| September 10, 2026 | 2.403 |
| September 09, 2026 | 2.497 |
| September 08, 2026 | 2.620 |
| September 04, 2026 | 2.687 |
| September 03, 2026 | 2.869 |
| September 02, 2026 | 3.046 |
| September 01, 2026 | 3.218 |
| August 31, 2026 | 3.333 |
| August 28, 2026 | 3.369 |
| August 27, 2026 | 3.620 |
| August 26, 2026 | 3.626 |
| August 25, 2026 | 3.658 |
| August 24, 2026 | 3.667 |
| August 21, 2026 | 3.579 |
| August 20, 2026 | 3.555 |
| August 19, 2026 | 3.550 |
| August 18, 2026 | 3.427 |
| August 17, 2026 | 3.575 |
| August 14, 2026 | 3.396 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Intellia Therapeutics, Inc. | 2.157 |
| Beam Therapeutics, Inc. | 2.327 |
| Prime Medicine, Inc. | 16.66 |
| Prelude Therapeutics, Inc. | 2.165 |
| Twist Bioscience Corp. | 19.67 |
Price to Book Value Related Metrics
| PE Ratio | 2.882 |
| PS Ratio | 2.385 |
| Price | 8.65 |
| Earnings Yield | 34.70% |
| Market Cap | 205.32M |
| Operating PE Ratio | 5.972 |
| Normalized PE Ratio | 2.877 |